Y 10.11:2019-07
|
Inflation, inflation expectations, and the Phillips curve |
1 |
Y 10.11:2019-08
|
CBO's Medicare beneficiary cost-sharing model : a technical description |
1 |
Y 10.11:2019-09
|
A summary of selected CBO reports on cash and accrual budgeting |
1 |
Y 10.11:2020-01
|
A simplified model of how macroeconomic changes affect the federal budget |
1 |
Y 10.11:2020-03
|
CBO's oil price forecasting record |
1 |
Y 10.11:2020-04
|
Federal reinsurance for terrorism risk and its effects on the budget |
1 |
Y 10.11:2020-05
|
Labor market effects of tax changes in times of high and low unemployment |
1 |
Y 10.11:2020-06
|
CBO's projection of the effect of climate change on U.S. economic output |
1 |
Y 10.11:2020-07
|
Key methods that CBO used to estimate the effects of pandemic-related legislation on output |
1 |
Y 10.11:2020-08
|
How CBO analyzes the costs of proposals for single-payer health care systems that are based on Medicare's fee-for-service program's |
1 |
Y 10.11:2020-09
|
The historical decline in real interest rates and its implications for CBO's projections |
1 |
Y 10.11:2021-01
|
CBO's model of drug price negotiations under the Elijah E. Cummings Lower Drug Costs Now Act |
1 |
Y 10.11:2021-02
|
Estimating the legal status of foreign-born people |
1 |
Y 10.11:2021-03
|
The economic effects of financing a large and permanent increase in government spending |
1 |
Y 10.11:2021-04
|
Discrete choice models for estimating labor supply |
1 |
Y 10.11:2021-05
|
Fair-value cost estimation and government cash flows |
1 |
Y 10.11:2021-06
|
Revisiting the extent to which payroll taxes are passed through to employees |
1 |
Y 10.11:2021-07
|
Governmental risk taking under market imperfections |
1 |
Y 10.11:2021-08
|
Fair-value budgeting : practical issues |
1 |
Y 10.11:2021-09
|
CBO's simulation model of new drug development |
1 |